Is Resgen overvalued or undervalued?

As of 17 September 2025, the valuation grade for Resgen has moved from fair to expensive, indicating that the company is currently overvalued. The key ratios reflect this assessment, with a PE ratio of 24.84, an EV to EBITDA of 13.07, and a PEG ratio of 1.16, all suggesting that the stock is trading at a premium compared to its earnings growth prospects.
In comparison to its peers, Resgen's PE ratio is lower than that of Larsen & Toubro, which stands at 32.69, but higher than many others in the sector, indicating a mixed competitive positioning. The EV to EBITDA ratio of 13.07 also appears more favorable than peers like CG Power & Ind, which is extremely expensive at 90.86. Despite a recent uptick in stock price, Resgen's year-to-date return of -19.2% versus the Sensex's 5.83% reinforces the notion that the stock may not be justified at its current valuation level.